FENC Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

SPRZEDAż 117008 min ago

@ $9.99

Wydano: 14 vas. 2024 @ 16:33

Zwrot: -7.61%

Poprzedni sygnał: vas. 13 - 16:38

Poprzedni sygnał: Kupno

Zwrot: -0.10 %

Live Chart Being Loaded With Signals

Commentary (3 geg. 2024 @ 23:00):

Stats
Dzisiejszy wolumen	71 279.00
Średni wolumen	136 767
Kapitalizacja rynkowa	250.13M
EPS	$0 ( 2024-03-21 )
Następna data zysków	( $-0.0400 ) 2024-05-09
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-15.38
ATR14	$0.0260 (0.28%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-30	Andrade Robert	Buy	1 042	Common shares
2024-04-30	Raykov Rosty	Buy	2 431	Common shares
2024-05-01	Raykov Rosty	Sell	2 431	Common shares
2024-04-18	Haigh Adrian	Buy	22 222	Common Shares
2024-04-17	Haigh Adrian	Buy	22 222	Common Shares

INSIDER POWER
8.49
Last 100 transactions
Buy: 1 356 995 \| Sell: 926 579

Wolumen Korelacja

Długi: 0.03 (neutral)

Krótki: -0.96 (very strong negative)

Signal:(34.82) Neutral

Fennec Pharmaceuticals Korelacja

10 Najbardziej pozytywne korelacje
JD	0.927
NAKD	0.916
GBNH	0.912
WLTW	0.907
SIRI	0.906
LSXMA	0.906
LSXMK	0.906
DTSS	0.905
ALXO	0.904
GOOD	0.903

10 Najbardziej negatywne korelacje
PAE	-0.924
GPACU	-0.915
CMLF	-0.909
LMNR	-0.909
PUCKU	-0.905
RAM	-0.905
GXII	-0.904
SGEN	-0.902
CSLMU	-0.9
EBSB	-0.896

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Fennec Pharmaceuticals Korelacja - Waluta/Towar

-0.23
( neutral )

-0.69
( moderate negative )

0.00
( neutral )

0.90
( strong )

0.63
( weak )

Fennec Pharmaceuticals Finanse

Annual	2023
Przychody:	$21.64M
Zysk brutto:	$20.36M (94.08 %)
EPS:	$-0.610

FY	2023
Przychody:	$21.64M
Zysk brutto:	$20.36M (94.08 %)
EPS:	$-0.610

FY	2022
Przychody:	$1.54M
Zysk brutto:	$1.45M (94.40 %)
EPS:	$-0.950

FY	2021
Przychody:	$0.00
Zysk brutto:	$0.00 (0.00 %)
EPS:	$-0.667

Financial Reports:

No articles found.

Fennec Pharmaceuticals

Fennec Pharmaceuticals Inc. operates as a biopharmaceutical company. Its product candidate in the clinical stage of development is PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity in pediatric cancer patients. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec Pharmaceuticals Inc. in September 2014. Fennec Pharmaceuticals Inc. was incorporated in 1996 and is based in Research Triangle Park, North Carolina.

Aktualne aktualizacje dla Fennec Pharmaceuticals [FENC]

Upcoming Earnings Alert